tobramycin - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
Pfizer (Australia) TOBRAMYCIN (as sulfate) PF 80 mg/2 mL injection ampoule
AUST R: 10776
Active ingredients:
tobramycin

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

From
08 Dec 2025
to
27 Feb 2026

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
Sponsor is closely controlling the supply. Alternative brands are available.
TOBI PODHALER tobramycin 28 mg hard capsule for inhalation blister pack with Podhaler device
AUST R: 182302
Active ingredients:
tobramycin

Dosage form:
Capsule, hard

Sponsor:
Viatris Pty Ltd

Phone:
1800 314 527

From
15 Nov 2025
to
27 Feb 2026

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
The sponsor is closely controlling the supply and working to expedite the next shipment.
TOBRAMYCIN WKT tobramycin 300mg/5mL solution for inhalation ampoules
AUST R: 279353
Active ingredients:
tobramycin

Dosage form:
Inhalation, conventional

Sponsor:
Arrotex Pharmaceuticals Pty Ltd

Phone:
1800 195 055

From
17 Apr 2026
to
22 May 2026

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
The sponsor is working to expedite the next shipment.
DBL TOBRAMYCIN tobramycin 80mg/2mL injection BP vial
AUST R: 75686
Active ingredients:
tobramycin

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

Deletion from market:
01 Apr 2026

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
An alternative generic product is available.
TOBI tobramycin 300mg/5mL solution for inhalation ampoule
AUST R: 73172
Active ingredients:
tobramycin

Dosage form:
Inhalation, conventional

Sponsor:
Viatris Pty Ltd

Phone:
1800 314 527

Deletion from market:
30 Jan 2026

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
An alternative brand is available.
TOBRAMYCIN SUN tobramycin 300 mg/5 mL solution for inhalation ampoule
AUST R: 285709
Active ingredients:
tobramycin

Dosage form:
Inhalation, conventional

Sponsor:
Sun Pharma ANZ Pty Ltd

Phone:
0298872600

Deletion from market:
01 May 2026

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Manufacturing

Management action:
Alternative generic products are available.